Cara Therapeutics to Reduce Staff by 50%, Focus Resources
By Will Feuer Cara Therapeutics said it plans to reduce its workforce by about 50% and focus its resources on one of its clinical trials in a bid to slash...
Stay updated with breaking news from Cara. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Will Feuer Cara Therapeutics said it plans to reduce its workforce by about 50% and focus its resources on one of its clinical trials in a bid to slash...
This week's retail ads saw widespread citrus promotions
Cara Therapeutics (NASDAQ:CARA – Get Free Report) had its target price lowered by investment analysts at Needham & Company LLC from $6.00 to $5.00 in a report released on Monday, Benzinga reports. The brokerage presently has a “buy” rating on the biopharmaceutical company’s stock. Other equities analysts have also issued reports about the stock. HC […]
This week's retail ads saw widespread citrus promotions